- Trifluperidol
- Trifluperidol hydrochloride
- 74915-66-53-ethoxy-6-methyl-3,5-androstadiene-11-beta-ol-17-one
- 74917-06-91H-Imidazole-1-propanal
- 7491-74-9Piracetam
- 74918-21-11,3-Bis(2,4-diaminophenoxy)propane tetrahydrochloride
- 74918-57-3Decanoyl chloride,2-hexyl-
- 749191-14-81,3-Benzodioxole-5-ethanamine,a,7-dimethyl-
- 749192-64-1(3R,4R)-Ethyl 4-phenylpiperidine-3-carboxylate
- 74919-31-6Pyridine,3-bromo-2-ethoxy-5-nitro-
- 74920-78-8Formaldehyde,1-(1-ethylhydrazinyl)-
- 749208-62-6Piperidine,3-(trifluoromethyl)-, (3S)-
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
|
Cas Database |
| Name |
Trifluperidol |
EINECS | N/A |
| CAS No. | 749-13-3 | Density | 1.26g/cm3 |
| PSA | 40.54000 | LogP | 4.72890 |
| Solubility | N/A | Melting Point |
N/A |
| Formula | C22H23 F4 N O2 | Boiling Point | 535.7°C at 760 mmHg |
| Molecular Weight | 409.424 | Flash Point | 277.8°C |
| Transport Information | N/A | Appearance | N/A |
| Safety | Poison by ingestion, subcutaneous, and intraperitoneal routes. An experimental teratogen. Experimental reproductive effects. When heated to decomposition it emits very toxic fumes of F− and NOx. See also FLUORIDES and TRIFLUPERIDOL HYDROCHLORIDE. | Risk Codes | N/A |
| Molecular Structure |
|
Hazard Symbols | N/A |
| Synonyms |
Butyrophenone,4'-fluoro-4-[4-hydroxy-4-(a,a,a-trifluoro-m-tolyl)piperidino]- (6CI,7CI,8CI);4'-Fluoro-4-[4-hydroxy-4-(a,a,a-trifluoro-m-tolyl)piperidino]butyrophenone;Flumoperone; McN-JR 2498; NSC 170978; P 459; Psicoperidol; R 2498;Trifluoperidol; Trifluperidol; Trifluperol; Triperidol; Trisedil; p-Fluoro-g-[4-hydroxy-4-(3-trifluoromethylphenyl)piperidino]butyrophenone |
Article Data | 4 |
Trifluperidol Chemical Properties
IUPAC Name: 1-(4-Fluorophenyl)-4-[4-hydroxy-4-[3-(trifluoromethyl)phenyl]-1-piperidyl]butan-1-one
Synonyms of Trifluperidol (CAS NO.749-13-3) : 1-Butanone, 1-(4-fluorophenyl)-4-(4-hydroxy-4-(3-(trifluoromethyl)phenyl)-1-piperidinyl)- ; 4'-Fluoro-4-(4-hydroxy-4-(alpha,alpha,alpha-trifluoro-m-tolyl)piperidino butyrophenone ; Flumoperone ; Psicoperidol ; Trifluperidol ; Trisedil ; Butyrophenone, 4'-fluoro-4-(4-hydroxy-4-(alpha,alpha,alpha-trifluoro-m-tolyl)piperidino)-
InChI:InChI=1/C22H23F4NO2/c23-19-8-6-16(7-9-19)20(28)5-2-12-27-13-10-21(29,11-14-27)17-3-1-4-18(15-17)22(24,25)26/h1,3-4,6-9,15,29H,2,5,10-14H2
CAS NO:749-13-3
Molecular Formula:C22H23F4NO2
Molecular Weight :409.4171
Molecular Structure :
Index of Refraction: 1.534
Surface Tension: 41.1 dyne/cm
Density: 1.26 g/cm3
Flash Point: 265.8 °C
Enthalpy of Vaporization: 82.95 kJ/mol
Boiling Point: 515.9 °C at 760 mmHg
Vapour Pressure: 1.8E-11 mmHg at 25°C
Trifluperidol Uses
Trifluperidol (CAS NO.749-13-3) is a typical antipsychotic of the butyrophenone chemical class.It is used in the treatment of psychoses including mania and schizophrenia.
Trifluperidol Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| cat | LD50 | subcutaneous | > 2500ug/kg (2.5mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 11, Pg. 932, 1961. | |
| dog | LD50 | subcutaneous | > 80mg/kg (80mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 11, Pg. 932, 1961. | |
| monkey | LD50 | subcutaneous | > 1250ug/kg (1.25mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 11, Pg. 932, 1961. | |
| mouse | LD50 | intravenous | 26mg/kg (26mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 11, Pg. 932, 1961. | |
| mouse | LD50 | oral | 110mg/kg (110mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: EXCITEMENT | Arzneimittel-Forschung. Drug Research. Vol. 24, Pg. 1248, 1974. |
| mouse | LD50 | subcutaneous | 50mg/kg (50mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: EXCITEMENT | Arzneimittel-Forschung. Drug Research. Vol. 24, Pg. 1248, 1974. |
| mouse | LDLo | intraperitoneal | 150mg/kg (150mg/kg) | National Technical Information Service. Vol. AD691-490, | |
| rat | LD50 | intravenous | 14mg/kg (14mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 11, Pg. 932, 1961. | |
| rat | LD50 | oral | 140mg/kg (140mg/kg) | Toxicology and Applied Pharmacology. Vol. 18, Pg. 185, 1971. | |
| rat | LD50 | subcutaneous | 70mg/kg (70mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE AUTONOMIC NERVOUS SYSTEM: CENTRAL SYMPATHOLYTIC BEHAVIORAL: ALTERATION OF CLASSICAL CONDITIONING | Medicinal Chemistry: A Series of Monographs. Vol. 4(2), Pg. 199, 1967. |
Trifluperidol Safety Profile
Poison by ingestion, subcutaneous, and intraperitoneal routes. An experimental teratogen. Experimental reproductive effects. When heated to decomposition it emits very toxic fumes of F− and NOx. See also FLUORIDES and TRIFLUPERIDOL HYDROCHLORIDE.
Trifluperidol Specification
Trifluperidol (CAS NO.749-13-3) has general properties similar to those of haloperidol, but is considerably more potent by weight, and causes relatively more severe side effects, especially tardive dyskinesia and other extrapyramidal effects.
What can I do for you?
Get Best Price
